MBX
Price
$29.86
Change
+$1.43 (+5.03%)
Updated
Dec 12 closing price
Capitalization
1.34B
Intraday BUY SELL Signals
VTYX
Price
$8.19
Change
-$0.31 (-3.65%)
Updated
Dec 12 closing price
Capitalization
584.43M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MBX vs VTYX

Header iconMBX vs VTYX Comparison
Open Charts MBX vs VTYXBanner chart's image
MBX Biosciences
Price$29.86
Change+$1.43 (+5.03%)
Volume$450.41K
Capitalization1.34B
Ventyx Biosciences
Price$8.19
Change-$0.31 (-3.65%)
Volume$1.85M
Capitalization584.43M
MBX vs VTYX Comparison Chart in %
MBX
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MBX vs. VTYX commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBX is a StrongBuy and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (MBX: $28.43 vs. VTYX: $8.50)
Brand notoriety: MBX and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBX: 97% vs. VTYX: 17%
Market capitalization -- MBX: $1.34B vs. VTYX: $584.43M
MBX [@Biotechnology] is valued at $1.34B. VTYX’s [@Biotechnology] market capitalization is $584.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBX’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • MBX’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, MBX is a better buy in the long-term than VTYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBX’s TA Score shows that 3 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • MBX’s TA Score: 3 bullish, 5 bearish.
  • VTYX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than MBX.

Price Growth

MBX (@Biotechnology) experienced а -6.91% price change this week, while VTYX (@Biotechnology) price change was +6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBX($1.34B) has a higher market cap than VTYX($584M). VTYX YTD gains are higher at: 288.128 vs. MBX (54.259). MBX has higher annual earnings (EBITDA): -90.62M vs. VTYX (-115.4M). MBX has more cash in the bank: 392M vs. VTYX (193M). MBX has less debt than VTYX: MBX (623K) vs VTYX (10M). MBX (0) and VTYX (0) have equivalent revenues.
MBXVTYXMBX / VTYX
Capitalization1.34B584M230%
EBITDA-90.62M-115.4M79%
Gain YTD54.259288.12819%
P/E Ratio3.89N/A-
Revenue00-
Total Cash392M193M203%
Total Debt623K10M6%
TECHNICAL ANALYSIS
Technical Analysis
MBXVTYX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
MBX
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GILAX13.660.11
+0.81%
Lord Abbett Fundamental Equity C
JHACX10.100.06
+0.60%
JHancock Multi-Asset Absolute Return C
SMFAX34.870.16
+0.46%
American Beacon Stephens Mid-Cap Gr A
GTAPX14.810.06
+0.41%
Glenmede Long/Short Eq Ptf
TRZVX52.98-6.09
-10.31%
T. Rowe Price Small-Cap Value Z

MBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBX has been loosely correlated with KOD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MBX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBX
1D Price
Change %
MBX100%
-1.35%
KOD - MBX
46%
Loosely correlated
-1.75%
NEVPF - MBX
40%
Loosely correlated
N/A
NUVL - MBX
32%
Poorly correlated
+0.16%
HOWL - MBX
32%
Poorly correlated
+1.87%
VTYX - MBX
32%
Poorly correlated
-2.19%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-2.19%
KYMR - VTYX
40%
Loosely correlated
-2.31%
IPSC - VTYX
39%
Loosely correlated
N/A
REPL - VTYX
38%
Loosely correlated
+0.51%
DSGN - VTYX
36%
Loosely correlated
-1.91%
ROIV - VTYX
36%
Loosely correlated
+5.43%
More